piracetam has been researched along with Psychoses, Drug in 12 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levetiracetam is a new anticonvulsant (AED) with a novel mechanism of action." | 5.31 | Levetiracetam psychosis in children with epilepsy. ( Bergey, GK; Freeman, JM; Kossoff, EH; Vining, EP, 2001) |
| "Clinically significant side effects of the new anticonvulsants, such as metabolic acidosis from topiramate, autoimmune reactions from lamotrigine, hyponatremia from oxcarbazepine, or psychosis from levitiracetam can cause serious morbidity and mortality if unrecognized." | 4.86 | Emergent complications of the newer anticonvulsants. ( Dang, CV; Nelson, L; Wade, JF; Wasserberger, J, 2010) |
| "Levetiracetam is an antiepileptic drug approved for use as an adjunct agent in partial-onset seizures in adults and children aged > or = 4 years." | 2.44 | The safety of levetiracetam. ( Safdieh, JE; Sirsi, D, 2007) |
| "Daytime somnolence was reported by 28 patients, 15 on OXC (10%); 8 received oral modafinil for the same, while none discontinued this AED." | 1.43 | Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy. ( Agarwal, P; Gupta, A; Poornima, S; Shukla, G, 2016) |
| "To investigate the hypothesis that some patients with epilepsy are generally prone to develop psychiatric adverse events (PAEs) during antiepileptic drug (AED) therapy irrespective of the mechanism of action of the drugs." | 1.34 | Are psychiatric adverse events of antiepileptic drugs a unique entity? A study on topiramate and levetiracetam. ( Mula, M; Sander, JW; Trimble, MR, 2007) |
| " A final dosage of 60 mg/kg was used." | 1.32 | Acute psychosis associated with levetiracetam. ( Karagianni, J; Lazopoulou, D; Michelakou, D; Youroukos, S, 2003) |
| "The prevalence and psychopathologic features of psychiatric adverse events (PAE) in 517 patients taking levetiracetam (LEV) were investigated." | 1.32 | Psychiatric adverse events during levetiracetam therapy. ( Liu, RS; Mula, M; Sander, JW; Trimble, MR; Yuen, A, 2003) |
| "Levetiracetam is a new anticonvulsant (AED) with a novel mechanism of action." | 1.31 | Levetiracetam psychosis in children with epilepsy. ( Bergey, GK; Freeman, JM; Kossoff, EH; Vining, EP, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shukla, G | 1 |
| Gupta, A | 1 |
| Agarwal, P | 1 |
| Poornima, S | 1 |
| Wade, JF | 1 |
| Dang, CV | 1 |
| Nelson, L | 1 |
| Wasserberger, J | 1 |
| Aggarwal, A | 1 |
| Sharma, DD | 1 |
| Sharma, RC | 1 |
| Kumar, R | 1 |
| Youroukos, S | 1 |
| Lazopoulou, D | 1 |
| Michelakou, D | 1 |
| Karagianni, J | 1 |
| Mula, M | 3 |
| Trimble, MR | 3 |
| Yuen, A | 1 |
| Liu, RS | 1 |
| Sander, JW | 2 |
| Bayerlein, K | 1 |
| Frieling, H | 1 |
| Beyer, B | 1 |
| Kornhuber, J | 1 |
| Bleich, S | 1 |
| Sirsi, D | 1 |
| Safdieh, JE | 1 |
| Roig, J | 1 |
| Carreño, MM | 1 |
| Parellada, E | 1 |
| Scheef, W | 1 |
| Kossoff, EH | 1 |
| Bergey, GK | 1 |
| Freeman, JM | 1 |
| Vining, EP | 1 |
2 reviews available for piracetam and Psychoses, Drug
| Article | Year |
|---|---|
Emergent complications of the newer anticonvulsants.
Topics: Acidosis; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Drug Overdose; Fructo | 2010 |
The safety of levetiracetam.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Blood Cells; Body Weight; Child; Child Behavior; Drug Hype | 2007 |
10 other studies available for piracetam and Psychoses, Drug
| Article | Year |
|---|---|
Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Disorders of Excessive Somnolence; Drug Re | 2016 |
Probable psychosis associated with levetiracetam: a case report.
Topics: Anticonvulsants; Epilepsies, Partial; Epilepsy, Tonic-Clonic; Humans; Levetiracetam; Male; Piracetam | 2011 |
Acute psychosis associated with levetiracetam.
Topics: Anticonvulsants; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy | 2003 |
Psychiatric adverse events during levetiracetam therapy.
Topics: Adult; Anticonvulsants; Female; Humans; Levetiracetam; Male; Piracetam; Prevalence; Psychoses, Subst | 2003 |
Drug-induced psychosis after long-term treatment with levetiracetam.
Topics: Adult; Female; Humans; Levetiracetam; Nootropic Agents; Piracetam; Psychoses, Substance-Induced; Tim | 2004 |
Re: Drug-induced psychosis with levetiracetam.
Topics: Acute Disease; Anticonvulsants; Humans; Levetiracetam; Piracetam; Psychoses, Substance-Induced; Seiz | 2005 |
[Probable levetiracetam-induced psychosis].
Topics: Anticonvulsants; Dose-Response Relationship, Drug; Epilepsy; Humans; Levetiracetam; Male; Middle Age | 2007 |
Are psychiatric adverse events of antiepileptic drugs a unique entity? A study on topiramate and levetiracetam.
Topics: Adult; Anticonvulsants; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Epilepsy | 2007 |
[Psychotic states of mind in the course of ifosfamide therapy and prevention with piracetam (Nootrop). Preliminary report].
Topics: Adult; Aged; Cyclophosphamide; Humans; Ifosfamide; Middle Aged; Neoplasms; Piracetam; Psychoses, Sub | 1983 |
Levetiracetam psychosis in children with epilepsy.
Topics: Acute Disease; Adolescent; Anticonvulsants; Child, Preschool; Comorbidity; Drug Administration Sched | 2001 |